Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Acasti Pharma Inc ACST

Acasti Pharma Inc. is a late-stage biopharma company with drug candidates addressing rare and orphan diseases. It is focused on developing and commercializing products for rare and orphan diseases that have the potential to improve clinical outcomes by using its drug delivery technologies. Its therapeutic pipeline consists of three clinical-stage drug candidates supported by an intellectual property portfolio of more than 40 granted and pending patents in various jurisdictions. Its lead drug candidate, GTX-104, is an intravenous infusion targeting aneurysmal Subarachnoid Hemorrhage (aSAH), a rare and life-threatening medical emergency in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull. Its other pipeline drug candidates: GTX-102 and GTX-101. GTX-102 is an oral-mucosal betamethasone spray for the treatment of Ataxia Telangiectasia. GTX-101 is a topical bio adhesive film-forming bupivacaine spray for Postherpetic Neuralgia.


NDAQ:ACST - Post by User

Bullboard Posts
Post by ROCKABERRYFINon Nov 11, 2012 3:42pm
220 Views
Post# 20586716

email from a friend

email from a friend

 

This is a very stressful time for us shareholders. What will happen going forward? Luckily both APO and NTB were both halted. If they werent I think the stocks wouldve gotten slaughtered. I wanted to share with you guys an email I got from a very smart businessman here in Canada who is a very close friend of my family. 
 
 
Hi xxxx
Your Mom tells me that the Neptune shares took a nasty hit on account of the fire at the their plant.  I'm thinking that you shouldn't be too quick to abandon the company.  Shareholders can be very quick to judge a situation and dump the shares but if Neptune is a good company and properly insured it could come out of this stronger than it was before.  In the short term they may be able to have some product contract-packed and in the long term build a new plant that will be more efficient and sized to the needs of the business.  According to Warren Buffet the way to make money is to buy good companies when the market has beaten them down for some reason.  If this is such a case it may mean this is actually an opportunity to buy more shares once their recovery plan is known.

xxxxx

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse